Target intelligence / Profile preview

Avidin (AVD)

Target
AVD
Molecular classification
Biotin-binding protein, Glycoprotein, Tetrameric protein, Other
01

Overview

Avidin is a tetrameric glycoprotein primarily found in the egg whites of birds, reptiles, and amphibians, while streptavidin is a homologous protein derived from the bacterium Streptomyces avidinii (UniProt P02701, P22629). Both proteins are characterized by their extraordinarily high affinity for biotin (vitamin B7), forming one of the strongest known non-covalent biological interactions with a dissociation constant (Kd) of approximately 10^-15 M (Green, N. M., 1975, Advances in Protein Chemistry). In a therapeutic context, these proteins are utilized as components in "pre-targeting" strategies, particularly for cancer imaging and radioimmunotherapy (Boerman, O. C., et al., 2003, Journal of Nuclear Medicine). In these applications, a biotinylated antibody is first administered to localize at a tumor site, followed by the administration of avidin or streptavidin, and finally a radiolabeled biotin molecule (Paganelli, G., et al., 1991, European Journal of Nuclear Medicine). This approach minimizes the exposure of healthy tissues to radiation by decoupling the slow-circulating antibody from the fast-clearing effector molecule. Despite their utility, the clinical use of avidin and streptavidin is limited by their potential immunogenicity in humans, which can lead to the development of anti-protein antibodies (Meyer, D. L., et al., 2001, Protein Science). Additionally, high levels of endogenous biotin in the blood can compete with the therapeutic biotinylated ligands, potentially reducing the efficacy of the system.

Other names
StreptavidinEgg white avidinBiotin-binding proteinStreptomyces avidinii streptavidin
02

Mechanism of action

High-affinity non-covalent binding to biotinylated ligands to facilitate localized delivery of therapeutic or diagnostic agents in pre-targeting protocols.

03

Biological functions

Biotin sequestrationHigh-affinity ligand bindingAntibacterial defenseOther
04

Disease associations

CancerInfectionOther
05

Safety considerations

Immunogenicity (HAAA/HASA response)Endogenous biotin interferenceRenal toxicity of radiolabeled biotinNon-specific liver uptake
06

Interacting drugs

Biotin

4 more in the full profile.

07

Biomarkers

Serum biotin levelsHuman anti-avidin antibodies (HAAA)Human anti-streptavidin antibodies (HASA)

Beyond the preview

Go deeper on Avidin (AVD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avidin (AVD).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call